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Abstract
Background: A cardiac origin in ischemic stroke is more fre-
quent than previously assumed, but it is not clear which pa-
tients benefit from cardiac work-up if obvious cardiac pa-
thology is absent. We hypothesized that thromboembolic 
stroke with a cardiac source occurs more frequently in the 
posterior circulation compared with thromboembolic stroke 
of another etiology. Methods: We performed a multicenter 
observational study in 3,311 consecutive patients with isch-
emic stroke who were enrolled in an ongoing prospective 
stroke registry of 8 University hospitals between September 
2009 and November 2014 in The Netherlands. In this initia-
tive, the so-called Parelsnoer Institute-Cerebrovascular Ac-
cident Study Group, clinical data, imaging, and biomaterials 
of patients with stroke are prospectively and uniformly col-
lected. We compared the proportions of posterior stroke lo-
cation in patients with a cardiac stroke source with those 
with another stroke etiology and calculated risk ratios (RR) 
with corresponding 95% CI with Poisson regression analy-
ses. To assess which patient or disease characteristics were 
most strongly associated with a cardiac etiology in patients 
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with ischemic stroke, we performed a stepwise backward re-
gression analysis. Results: For the primary aim, 1,428 pa-
tients were eligible for analyses. The proportion of patients 
with a posterior stroke location among patients with a car-
diac origin of their stroke (28%) did not differ statistically sig-
nificant to those with another origin (25%), age and sex ad-
justed RR 1.16; 95% CI 0.96–1.41. For the secondary aim, 
1,955 patients were eligible for analyses. No recent history of 
smoking, no hyperlipidemia, coronary artery disease, a high-
er age, and a higher National Institutes of Health Stroke Scale 
(NIHSS) score were associated with a cardiac etiology of isch-
emic stroke. Conclusions: We could not confirm our hypoth-
esis that thromboembolic stroke localized in the posterior 
circulation is associated with a cardioembolic source of isch-
emic stroke, and therefore posterior stroke localization on 
itself does not necessitate additional cardiac examination. 
The lack of determinants of atherosclerosis, for example, no 
recent history of smoking and no hyperlipidemia, coronary 
artery disease, a higher age, and a higher NIHSS score are 
stronger risk factors for a cardiac source of ischemic stroke.
© 2020 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Based on studies demonstrating that prolonged and 
continuously heart rhythm monitoring in patients at risk of 
atrial fibrillation (AF) and in patients with cryptogenic 
stroke, it is now recognized that cardiac embolism is a more 
frequent cause for thromboembolic stroke than previously 
thought [1–3]. A pragmatic approach in which patients 
with an ischemic stroke of undetermined source were treat-
ed with rivaroxaban, an oral factor Xa inhibitor, was studied 
in a clinical trial showing that rivaroxaban was not superior 
to aspirin with regard to the prevention of recurrent stroke 
and was associated with a higher risk of bleeding [4]. A more 
recent study showed that the oral direct thrombin inhibitor 
dabigatran was also not superior to aspirin in preventing 
recurrent stroke with more clinically relevant nonmajor 
bleeding events in the dabigatran group [5]. Therefore, 
proper selection of patients with a high chance of cardioem-
bolic stroke for which secondary prevention with an oral 
factor Xa inhibitor will be beneficial is needed.
Phenotyping of patients with an ischemic stroke of un-
determined source with high risk of a cardiac etiology, for 
example, AF or patent foramen ovale (PFO), may in-
crease the efficacy of additional cardiac workup. Al-
though several characteristics, including strokes in differ-
ent vascular territories, isolated aphasia [6], increased 
age, male sex, heart failure, and pulmonary disease, are 
associated with AF occurrence, no clear evidence exists 
which (combination of) risk factors identify the patients 
who would derive the most clinical benefit from detection 
of AF by prolonged monitoring.
We found in a single-hospital retrospective observa-
tional study in 7,454 consecutive patients after cardiac 
surgery in which we assumed that all perioperative throm-
boembolic strokes are of cardiac origin, and that throm-
boembolic stroke after cardiac surgery occurs twice as of-
ten in the posterior cerebral circulation compared with 
ischemic strokes in the general population [7]. This risk 
was further increased in presence of multiple strokes. If 
these findings are confirmed in general stroke cohorts, 
ischemic stroke located in the posterior cerebral circula-
tion may lower the threshold for initiating additional car-
diac diagnostic studies in order to point toward a cardiac 
source in these patients.
The primary aim of the current study was to confirm in 
a large independent cohort that strokes with a cardiac eti-
ology are more often located in the posterior circulation 
area than strokes of another etiology. The secondary aim 
was to study the association of clinical characteristics with 
cardioembolic strokes in patients with ischemic stroke.
Methods
Study Population and Definition of Stroke
We included patients with cerebral ischemia, including both 
ischemic stroke and transient ischemic attack (TIA), who were en-
rolled in an ongoing prospective registry of 8 University hospitals 
between September 2009 and November 2014 in The Netherlands 
[8]. In this initiative, the so-called Parelsnoer Institute-Cerebro-
vascular Accident Study Group, clinical data, imaging, and bioma-
terials of patients with stroke are prospectively and uniformly col-
lected. We approached all eligible patients, or a next of kin when 
patients were unconsciousness or mentally incompetent, for in-
formed consent within the first 3 months after the event. The Eth-
ics Committees of all participating centers approved the study, and 
all patients provided written informed consent.
Ischemic stroke and TIA were defined according to the World 
Health Organization criteria for stroke [9]. We further classified 
ischemic stroke into specific subtypes according to Trial of Org 
10172 in Acute Stroke Treatment (TOAST) classification: large ar-
tery atherosclerosis, small vessel disease, cardioembolic stroke, 
other determined cause, and undetermined cause [10]. Patients 
determined with definitive cardioembolic stroke according to the 
A-S-C-O classification were also considered as cardioembolic 
stroke if TOAST classification was missing or undetermined [11]. 
Cardioembolic stroke was not further differentiated into AF or 
otherwise.
We categorized stroke localization based on the modified Ox-
fordshire method that classifies the infarcts based on their ana-
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tomic distribution into 4 groups: total anterior circulation infarcts, 
partial anterior circulation infarcts, posterior circulation infarcts, 
and lacunar infarcts [12]. Patients with infarcts in multiple territo-
ries that involved the posterior cerebral circulation were consid-
ered posterior circulation infarct patients in the primary analysis.
Statistical Analyses
We compared the proportion of patients with a posterior stroke 
location among patients with a cardiac origin of their stroke and 
those with another origin and calculated a risk ratio (RR) with cor-
responding 95% CI. In additional Poisson regression analyses, we 
assessed the influence of adjustment of the crude RRs for potential 
confounders [13]. Bivariable analyses were performed with all pa-
tient and baseline characteristics mentioned in Table 1 with excep-
tion of AF as this already assumes a history of AF and a cardiac 
etiology in the workup of the Parelsnoer Institute-Cerebrovascular 
Accident Study Group. If the tested variable changed the crude RR 
of posterior stroke > 10% the variable was used in the subsequent 
multivariable analyses. A sensitivity analysis was performed in 
which patients with a TIA were excluded.
To assess if patient or disease characteristics were associated 
with a cardiac etiology in patients with ischemic stroke, we per-
formed a stepwise logistic regression analysis using a p value of 
0.10 to eliminate variables with the backward method. The full 
model consisted of patient and baseline characteristics mentioned 
in Table 1, again with exception of AF. Use of oral anticoagulants 
and antiplatelets was excluded because of confounding by indica-
tion. Variables with > 20% missing’s were also excluded. Thereaf-
ter, a risk score was calculated using the beta’s of the remaining 
variables in the model. Discrimination of the risk score was calcu-
lated with the concordance (c) statistic and corresponding receiv-
er operating characteristic curve.
Missing values were not imputed in our analyses. 
Data Availability
The data that support the findings of this study are available 
from the corresponding author upon reasonable request.
Results
The database contained 3,311 patients with an isch-
emic stroke or TIA. For the primary aim, 1,212 patients 
were excluded because stroke localization was undeter-
Table 1. Baseline characteristics of 2,334 patients based on cardioembolism (n = 578) as source for ischemic stroke 
or TIA or not (n = 1,756)
Variable Cardioembolism
(n = 578), n (%)
No cardioembolism
(n = 1,756), n (%)
p value
BMI, mean ± SD* 26±5 26±4 0.98
NIHSS score, median (IQR)* 3 (1–8) 2 (0–5) <0.001
Age, years, mean ± SD 70±15 65±14 <0.001
Age category per decade
0–20
21–30
31–40
41–50
51–60
61–70
71–80
81–90
91–100
4 (1)
8 (1)
17 (3)
42 (7)
62 (11)
141 (24)
173 (30)
113 (20)
18 (3)
8 (1)
12 (1)
61 (3)
177 (10)
342 (19)
530 (30)
416 (24)
187 (11)
23 (1)
<0.001
Gender, male 352 (61) 1,043 (59) 0.52
Hypertension 342 (60) 986 (56) 0.19
Hyperlipidemia 188 (33) 655 (37) 0.08
Diabetes mellitus 97 (17) 289 (16) 0.72
Coronary artery disease 139 (24) 288 (16) <0.001
Peripheral arterial occlusion disease 50 (9) 170 (10) 0.57
Recent (<6 month) history of smoking 94 (16) 572 (33) <0.001
Use of oral anticoagulants (prior to stroke) 85 (15) 173 (10) <0.001
Use of antiplatelets (prior to stroke) 201 (35) 728 (41) 0.012
History of migraine* 51 (9) 197 (11) 0.095
AF (paroxysmal) 292 (51) 54 (3) <0.001* >3% missing’s (BMI 24%, NIHSS 18%, and migraine 35% unknown).
TIA, transient ischemic attack; BMI, body mass index; NIHSS, National Institutes of Health Stroke Scale; AF, 
atrial fibrillation.
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mined, and another 671 patients were excluded because 
stroke etiology was undetermined leaving 1,428 eligible 
patients for analyses. For the secondary aim, 977 patients 
were excluded because stroke etiology was undeter-
mined, for example, incomplete cardiac work-up. An-
other 379 patients were excluded because variables con-
tain too many missing’s or patients already used antico-
agulants leaving 1,955 eligible patients for analyses 
(Fig. 1).
In 578 (18%) patients, the source of cerebral ischemia 
was cardioembolism (Table 2). Patients with cardioem-
bolic stroke had increased age, a higher National Insti-
tutes of Health Stroke Scale (NIHSS) score, had more of-
ten a history of coronary disease, and were less often cur-
rent or recent smokers than patients with another stroke 
type (Table 1).
The proportion of patients with a posterior stroke lo-
cation among patients with a cardiac origin of their stroke 
(28%) was not significantly higher compared to those 
with another origin (25%): RR 1.14; 95% CI 0.94–1.37 
(Table 3). Baseline characteristics with > 3% missing val-
ues (body mass index, NIHSS score and migraine) were 
not used for bivariable analyses as this would decrease the 
number of included patients substantially. None of the 
remaining variables had a large influence on the crude RR 
for posterior stroke, and therefore only age and sex were 
used in the multivariable analyses. As a result, the addi-
tional Poisson regression analyses to assess the influence 
of these potential confounders only marginally changed 
the RR 1.16; 95% CI 0.96–1.41.
When only patients with a known duration of symp-
toms longer than 24 h were included, that is, exclusion of 
patients with a TIA, 1,112 patients remain eligible for 
Poisson regression analyses. This marginally changed the 
proportion of patients with a posterior stroke (28%) com-
pared to those with another origin (30%) in case of a car-
diac source; age and sex adjusted RR 0.91; 95% CI 0.67–
1.24.
With the stepwise backward regression analyses, we 
found that a history of coronary artery disease, higher age, 
and a higher NIHSS score were related to cardioembolic 
stroke, while current or recent smoking and hyperlipid-
Ischemic stroke or TIA
(n = 3,311)
Used for analyses 1st aim
(n = 1,428)
Posterior stroke (n = 369)
Anterior stroke (n = 1,059)
Cardioembolism (n = 388)
No cardioembolism (n = 1,040)
Cardioembolism (n = 455)
No cardioembolism (n = 1,500)
Used for analyses 2nd aim
(n = 1,955)
1,212 excluded
• Stroke localization
 undetermined
977 excluded
• Cardiac source missing (n = 33)
 or undetermined/incomplete
 workup (n = 944)
379 excluded
• >20% missing’s (BMI, migraine,
 posterior stroke)
• Use of OAC or antiplatelets
671 excluded
• Cardiac source
 undetermined/
 incomplete workup
Fig. 1. Flowchart of included patients. TIA, 
transient ischemic attack
Table 2. Stroke etiology in all 3,311 patients with ischemic stroke 
or TIA
Stroke subtype n (%)
Atherosclerosis
Cardioembolism
Small vessel occlusion (lacune)
Other
Undetermined
Unknown
802 (24)
578 (18)
623 (19)
321 (10)
944 (29)
43 (1)
TIA, transient ischemic attack.
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emia were inversely related with cardioembolic stroke (Ta-
ble 4). The chance for cardioembolic etiology of ischemic 
stroke based on the risk score ranged from 11.7% for the 
first quartile to 36.8% for the fourth quartile (Table 5). The 
C-statistic (area under the curve of the receiver operating 
characteristic curve) was 0.65 (95% CI 0.62–0.68) (Fig. 2).
Discussion
The goal of our study was to measure an association 
between a cardiac etiology of stroke and posterior stroke 
localization, and in addition to describe the precision of 
that measurement. The major finding of this study is that 
we could not confirm our hypothesis that a posterior lo-
calization of thromboembolic stroke is associated with a 
cardioembolic source for ischemic stroke. However, clas-
sification of this study as strictly negative is potentially 
misleading, because such classification is done on basis of 
CIs, the magnitude of which is determined both by effect 
size and precision. With only 5 more cardioembolic 
strokes in the posterior localization, the results would have 
been statistically significant. However, the trend is only 
small, and therefore stroke localization on itself has hard-
ly any additional value in the consideration to perform 
cardiac examination after ischemic stroke of undeter-
mined source. Furthermore, the sensitivity analysis with-
out patients with TIAs neither showed an effect. We per-
formed this additional analysis because in these patient’s 
radiographic conformation of infarction in the posterior 
circulation is not possible and in some occasions clinical 
symptoms of TIA are caused by nonvascular events.
A history of coronary artery disease, a higher age and 
NIHSS score, and lack of determinants of atherosclerosis 
increased the chance of a cardiac source of the stroke. Al-
though the ability of the risk model to discriminate be-
tween patients with or without a cardiac source of isch-
emic stroke is only moderate, these clinical characteristics 
may necessitate a further exploration on a cardiac source 
for ischemic stroke. This is clinically relevant as in pa-
tients with a previous stroke in the presence of AF, use of 
antiplatelet agents will prevent 40 vascular events per 
1,000 patients per year, whereas coumarins will prevent 
90 vascular events per 1,000 patients per year [14]. Factor 
Xa inhibitors further boost the prevention rate with 22% 
(to 110) compared with coumarins [15], so estimated re-
duction of vascular events is 70 per 1,000 patients per year 
in patients detected with AF after ischemic stroke and in 
whom antiplatelet agents are changed to an oral factor Xa 
inhibitor. The number needed to treat, with anticoagu-
lants, to prevent 1 vascular event per year is 9.
Our findings are in line with a cohort study in stroke 
patients in which patients with carotid stenosis, other ap-
parent stroke causes such as dissection or vasculitis, or an 
apparent embolic source were excluded. The authors 
found that multiple ischemic lesion patterns in the poste-
rior circulation were associated with the presence of a 
Table 3. Chance for cardioembolic etiology of ischemic stroke in case of posterior localization
Cardioembolism
(n = 388), n (%)
No cardioembolism
(n = 1,040), n (%)
Relative risk
(95% CI)
Adjusted* relative
risk (95% CI)
Posterior stroke 110 (28) 259 (25) 1.14 (0.94–1.37) 1.16 (0.96–1.41)
Anterior stroke 278 (72) 781 (75)* Adjusted for age and sex.
Table 4. Chance for cardioembolic etiology of ischemic stroke 
based on stepwise backward logistic regression
Beta OR (95% CI)
Recent or current smoking –0.755 0.47 (0.36–0.62)
Hyperlipidemia –0.297 0.74 (0.59–0.94)
NIHSS score (per point increase) 0.058 1.06 (1.04–1.08)
Age (per year increase) 0.013 1.01 (1.01–1.02)
Coronary artery disease 0.436 1.55 (1.17–2.05)
NIHSS, National Institutes of Health Stroke Scale.
Table 5. Chance for cardioembolic etiology of ischemic stroke 
based on risk score
Risk score Risk of cardiac source, %
Q1 <0.4633 11.7
Q2 0.4633–0.8804 21.5
Q3 0.8804–1.1917 23.1
Q4 >1.1917 36.8
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PFO [16]. Based on a 99mTc-MAA Brain SPECT study, 
this may be caused by an increased blood flow in the pos-
terior circulation compared with that in the anterior cir-
culation in right-to-left shunting during a Valsalva ma-
neuver [17]. Although PFO-related stroke may not be a 
good model for cardioembolism in general, to our knowl-
edge, there are no other studies on well-established car-
dioembolic causes and stroke distribution exploring oth-
er plausible biological explanations.
Our findings are in line with a study that aimed to de-
termine if lesion patterns on early diffusion-weighted im-
aging are associated with stroke subtypes determined by 
the TOAST classification [18]. In a cohort of 172 stroke 
patients, there were 21 in the posterior circulation (5 sin-
gle lesions in the posterior circulation and 16 multiple le-
sions in both anterior and posterior circulation) of which 
12 (57%) were cardioembolic strokes and 6 were undeter-
mined. They also found that single corticosubcortical le-
sions were associated with cardioembolic stroke. Unfor-
tunately, our database did not describe the topography of 
stroke lesions in such detail, so we were unable to confirm 
these findings. Furthermore, they found that multiple le-
sions in anterior and posterior circulations and multiple 
lesions in multiple cerebral circulations were associated 
with cardioembolism. Multiple lesions in the unilateral 
anterior circulation and small scattered lesions in 1 vas-
cular territory were related to large-artery atherosclerosis. 
A larger study in 510 patients confirmed that multiple le-
sions in 1 anterior circulation territory suggest large-ar-
tery atherosclerosis, while multiple lesions in multiple 
territories (bilateral or anterior-posterior circulation) 
were associated with cardiogenic embolism [19]. They 
did, however, not look specific to single lesions in the pos-
terior circulation.
The findings of our study are only partly in line with 
our previous study in patients with thromboembolic 
stroke after cardiac surgery [7], as the relative risk for a 
posterior location for stroke after cardiac surgery com-
pared to patients with ischemic stroke without prior car-
diac surgery in that study was substantial higher: 2.09 
(95% CI 1.60–2.72) vs. 1.16 (95% CI 0.96–1.41) in the cur-
rent study. Stroke after cardiac surgery is not identical to 
cardioembolic stroke, but this difference may also be ex-
plained by the large number of patients in which stroke 
localization and etiology were undetermined in the cur-
rent study, and it may well be that this was not at random, 
for example, exploring a cardiac source was not performed 
in very old patients or in those with a high NIHSS, leading 
to a bias by indication. Furthermore, although AF is an 
established risk factor for stroke in the general population, 
it is postulated that AF is not always the cause of cardio-
embolic stroke, but in part may be considered as a risk 
marker for stroke. This is especially the case in device-
detected subclinical AF (SCAF) which is detected in up to 
40% of individuals with implantable pacemakers and de-
fibrillators capable of long-term continuous heart rhythm 
monitoring [20, 21]. Fewer than 20% individuals with 
SCAF who had stroke during a cohort study that  enrolled 
2,580 pacemaker and defibrillator patients aged ≥65 years 
with a history of hypertension but without a history of AF 
had evidence of SCAF in the 30 days preceding the stroke 
[22]. Stroke mechanism in (particularly subclinical) AF 
may therefore not always be cardioembolic. However, in 
the Parelsnoer Institute-Cerebrovascular Accident Study 
Group, cardioembolism was considered definitive if pa-
tients had a history of AF or if it was detected thereafter, 
although based on the abovementioned findings not all 
strokes in AF patients necessarily had a cardiac etiology 
and therefore might dilute the association between car-
dioembolism and posterior stroke localization. The num-
ber of SCAF patients was not registered in the Parelsnoer 
Institute-Cerebrovascular Accident Study Group so the 
contribution of this diluting effect is unknown.
Our findings are based on data acquired in a large pro-
spective nationwide cohort study enlarging the generaliz-
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Fig. 2. ROC curve of risk score. C-statistic (AUC-ROC) is 0.65 
(95% CI 0.62–0.68). ROC, receiver operating characteristic.
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ability of the results. Clinical consequences may be that in 
presence of posterior stroke localization in stroke with 
undetermined source, the threshold for performing ad-
ditional cardiac examination and monitoring is slightly 
lowered. The need for cardiac examination may be more 
pressing in concomitant presence of male sex, a high 
 NIHSS score, and no history of recent smoking and hy-
perlipidemia.
Phenotyping of patients with ischemic stroke of unde-
termined source with a higher risk for AF may increase 
the efficacy of additional cardiac work up. Although sev-
eral parameters, including increased multiple strokes, age 
and male sex, are associated with AF occurrence, no clear 
evidence exists which (combination of) risk factors iden-
tify those patients who would benefit most from extensive 
cardiac monitoring. Added to known risk factors from 
the literature, our findings suggest that patients with pos-
terior stroke localization in absence of determinants for 
atherosclerosis should be offered additional cardiac in-
vestigations. Prospective studies must confirm if in a phe-
notyping-based selection of patient’s additional cardiac 
investigations for AF diagnosis and subsequent therapeu-
tic intervention are indeed cost effective.
The most important limitation of our study is, in spite 
of the prospective nature of the cohort, the large number 
of patients in who stroke localization or etiology was un-
determined. This underlines the challenges of perform-
ing a large multicenter prospective cohort study. How-
ever, with 1,428 patients from 8 University hospitals in-
cluded in the primary analysis, the dataset is nevertheless 
large enough to allow sufficiently precise conclusions for 
an analysis that consists of a single characteristic (poste-
rior stroke) with 13 potential confounders and 1 outcome 
(cardioembolic stroke) that occurred in 388 patients. The 
1,955 patients included in the secondary analyses are 
more than enough for the backward stepwise regression 
analysis that consisted of 14 variables and one outcome 
that occurred in 578 patients and even more variables 
could be included in the model without overfitting it 
when used in future studies.
Conclusion
Localization in the posterior circulation is not clearly 
associated with a cardioembolic source for ischemic 
stroke, and therefore posterior stroke localization on it-
self is no strong indication for additional cardiac work up. 
The lack of determinants of atherosclerosis is stronger 
related with a cardiac source of ischemic stroke and may 
emphasize the need for cardiac examinations.
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